Literature DB >> 34738218

A Case-Control Study of Follicular Fluid Cytokine Profiles in Women with Diminished Ovarian Reserve.

Ruo-Pan Huang1, Anna K Knight2, Sina Abhari3, Jingqiao Lu1, Heather S Hipp3, Brianne Petritis1, Sabrina A Gerkowicz4, Quinton S Katler3, Haw-Han Yen1, Yingqing Mao1, Hao Tang1, Weirong Shang3, Laurie J McKenzie5, Alicia K Smith6.   

Abstract

Ovarian reserve is an important determinant of a woman's reproductive potential, and women with diminished ovarian reserve (DOR) often seek in vitro fertilization (IVF). The underlying etiology of DOR is unknown, but follicular fluid cytokine concentrations likely play a role in follicular development and maturation. The present study seeks to investigate the expression of cytokines in follicular fluid (FF) of women with DOR undergoing IVF and explore correlated functional pathways. One hundred ninety-four women undergoing ovarian stimulation were recruited at the time of oocyte retrieval. Women were classified as having DOR if they met one or more of the following criteria: AMH < 1 ng/ml, FSH > 10 mIU/ml, and/or AFC < 10. Controls included women undergoing IVF for male factor, tubal factor due to tubal ligation, or planned oocyte cryopreservation (non-oncologic). The concentrations of 480 cytokines and related growth factors in follicular fluid were determined using a multiplex immunoassay. Fifty-nine cytokines had significantly different concentrations (53 higher and 6 lower) in the DOR relative to the control group after adjusting for age and body mass index (BMI) (false discovery rate; FDR < 0.1). Using the most informative 44 biomarkers as indicated by a random forest (RF) model, an area under the curve (AUC) of 0.78 was obtained. Thus, follicular microenvironment differs between women with DOR and normal ovarian reserve. The differentially expressed cytokines belong to diverse processes that are primarily involved in follicular maturation and ovulation. These changes may play an important role in treatment outcomes in women with DOR.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Cytokines; Diminished ovarian reserve; Follicular fluid; In vitro fertilization

Mesh:

Substances:

Year:  2021        PMID: 34738218     DOI: 10.1007/s43032-021-00757-2

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  39 in total

Review 1.  Ovarian aging: mechanisms and clinical consequences.

Authors:  F J Broekmans; M R Soules; B C Fauser
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

Review 2.  Long-term health consequences of premature or early menopause and considerations for management.

Authors:  S S Faubion; C L Kuhle; L T Shuster; W A Rocca
Journal:  Climacteric       Date:  2015-04-07       Impact factor: 3.005

Review 3.  Cardiovascular health and ovarian aging.

Authors:  Molly M Quinn; Marcelle I Cedars
Journal:  Fertil Steril       Date:  2018-10       Impact factor: 7.329

4.  Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.

Authors:  Anne Z Steiner; David Pritchard; Frank Z Stanczyk; James S Kesner; Juliana W Meadows; Amy H Herring; Donna D Baird
Journal:  JAMA       Date:  2017-10-10       Impact factor: 56.272

5.  Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.

Authors:  O Hamdine; M J C Eijkemans; E W G Lentjes; H L Torrance; N S Macklon; B C J M Fauser; F J Broekmans
Journal:  Hum Reprod       Date:  2014-10-29       Impact factor: 6.918

Review 6.  Environmental and developmental origins of ovarian reserve.

Authors:  M C Richardson; M Guo; B C J M Fauser; N S Macklon
Journal:  Hum Reprod Update       Date:  2013-11-27       Impact factor: 15.610

7.  Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.

Authors:  S J Morin; G Patounakis; C R Juneau; S A Neal; R T Scott; E Seli
Journal:  Hum Reprod       Date:  2018-08-01       Impact factor: 6.918

Review 8.  Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Authors:  Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars
Journal:  J Assist Reprod Genet       Date:  2017-10-02       Impact factor: 3.412

9.  Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.

Authors:  Valerie L Baker; Clarisa Gracia; Michael J Glassner; Vicki L Schnell; Kevin Doody; Charles C Coddington; Sanghyuk S Shin; Lorna A Marshall; Michael M Alper; Arlene J Morales; Mary Ellen Pavone; Millie A Behera; Edward A Zbella; Bruce S Shapiro; Joely A Straseski; Dennis L Broyles
Journal:  Fertil Steril       Date:  2018-06-28       Impact factor: 7.329

10.  Assisted Reproductive Technology Surveillance - United States, 2016.

Authors:  Saswati Sunderam; Dmitry M Kissin; Yujia Zhang; Suzanne G Folger; Sheree L Boulet; Lee Warner; William M Callaghan; Wanda D Barfield
Journal:  MMWR Surveill Summ       Date:  2019-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.